Granted Patent
B2
US 7,196,186 · App. 10/757,343 · Granted Mar 27, 2007
DNA composition and uses thereof
View Patent ↗
Loading inventors, assignments & file history…
Abstract
A plasmid DNA that encodes one or more antigenic genes operably linked to a promoter and a truncated retroviral 3′ LTR exhibits both enhanced safety and acceptable efficiency of expression of antigenic proteins.
Claims (2)
1. A composition comprising the nucleic acid of SEQ ID NO. 2.
2. A composition comprising the nucleic acid of SEQ ID NO. 3.
Assignments (4)
SECURITY INTEREST
Recorded Jun 4, 2014
From: GENETIC IMMUNITY, KFT
To: TRIDENT GROWTH FUND, L.P.
Reel/Frame 033085/0259 →
SECURITY AGREEMENT
Recorded Sep 28, 2007
From: GENETIC IMMUNITY, LLP
To: TRIDENT GROWTH FUND, LLP; WILSON, WILL; PRONTO, ROD; WALTON, STEVE; VELA, DANNY; SASSER, FORD; BROWDER, ANDY; WILSON, HILTON
Reel/Frame 019892/0606 →
SECURITY AGREEMENT
Recorded Aug 31, 2007
From: GENETIC IMMUNITY, LLC
To: WILSON, HILTON; BROWDER, ANDY; TRIDENT GROWTH FUND, LP; VELA, DANNY; SASSER, FORD; RODMAN & RENSHAW, LLC; PRONTO INVESTMENTS, LTD; WILSON, WILL; WALTON, STEVE
Reel/Frame 019767/0755 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Feb 7, 2007
From: LISZIEWICZ, JULIANNA; LORI, FRANCO; XU, JIANQING
To: RESEARCH INSTITUTE FOR GENETIC AND HUMAN THERAPY
Reel/Frame 018867/0338 →
Continuity (2)
Provisional Application
6044024500
· Jan 15, 2003